Emerging treatment for Sjögren's disease: A review of recent phase II and III trials

RI Fox, CM Fox, SS McCoy - Expert Opinion on Emerging Drugs, 2023 - Taylor & Francis
Introduction Sjögren's Disease, SjD, is a systemic autoimmune disorder characterized by
reduced function of the salivary and lacrimal glands. Patients suffer from dryness, fatigue …
被引用次数：6 相关文章

Emerging treatment for Sjögren's disease: a review of recent phase II and III trials.

RI Fox, CM Fox, SS McCoy - Expert Opinion on Emerging Drugs, 2023 - europepmc.org
Sjögren's Disease, SjD, is a systemic autoimmune disorder characterized by reduced
function of the salivary and lacrimal glands. Patients suffer from dryness, fatigue, and pain …

Emerging treatment for Sjögren's disease: a review of recent phase II and III trials

RI Fox, CM Fox, SS McCoy - Expert opinion on emerging …, 2023 - pubmed.ncbi.nlm.nih.gov
Introduction Sjögren's Disease, SjD, is a systemic autoimmune disorder characterized by
reduced function of the salivary and lacrimal glands. Patients suffer from dryness, fatigue …